healthmedicinet
Daily News and Tips
MENU
A-Z Health Topics
Medical Conditions
Symptoms
Interactive Tools
Drugs, Supplements
Archive
March 25, 2015
CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer
news
CASI Pharmaceuticals, Inc.
←
Previous
Next
→